The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10180 malaria professionals are enjoying the free benefits of MalariaWorld today

Plasmodium falciparum

Not Open Access | The walking dead: Is hydroethidine a suitable viability dye for intra-erythrocytic Plasmodium falciparum?

September 12, 2012 - 04:30 -- Patrick Sampao
Author(s): 
Dewaldt Engelbrecht, Thérèsa Louise Coetzer
Reference: 
Parasitology International, Volume 61, Issue 4, December 2012, Pages 731-734

MalariaWorldWe compared flow cytometric quantification by hydroethidine and thiazole orange in P. falciparum.

Not Open Access | Toward understanding the role of mitochondrial complex II in the intraerythrocytic stages of Plasmodium falciparum: Gene targeting of the Fp subunit

September 12, 2012 - 04:25 -- Patrick Sampao
Author(s): 
Takeshi Q. Tanaka, Makoto Hirai, Yoh-ichi Watanabe, Kiyoshi Kita
Reference: 
Parasitology International, Volume 61, Issue 4, December 2012, Pages 726-728

MalariaWorldTo elucidate the physiological role of Plasmodium falciparum mitochondrial complex II (succinate-ubiquinone reductase (SQR) or succinate dehydrogenase (SDH)) in the TCA cycle, the gene for the flavoprotein subunit (Fp) of the enzyme, pfsdha (P.falciparum gene for SDH subunit A, PlasmoDB ID: PF3D7_1034400) was disrupted.

Impact of pre-existing MSP142-allele specific immunity on potency of an erythrocytic Plasmodium falciparum vaccine

September 11, 2012 - 07:01 -- Kabogo Ndegwa
Author(s): 
Bergmann-Leitner ES, Duncan EH, Mease RM, Angov E
Reference: 
Malaria Journal 2012, 11:315 (7 September 2012)

MalariaWorldThe development of a more broadly efficacious MSP1 based vaccine may be hindered by clonally imprinted p33 responses mainly restricted at the T cell level.

Medical Condition: 
Medical Treatment: 

Investigation of volatile organic biomarkers derived from Plasmodium falciparum in vitro

September 11, 2012 - 06:54 -- Kabogo Ndegwa
Author(s): 
Wong RP, Flemati GR, Davis TM
Reference: 
Malaria Journal 2012, 11:314 (7 September 2012)

MalariaWorldFuture in vivo studies analysing the breath of patients with severe malaria who are harbouring a parasite biomass that is significantly greater than achievable in vitro may yet reveal specific clinically-useful volatile chemical biomarkers.

Medical Condition: 

Optimization of flow cytometric detection and cell sorting of transgenic Plasmodium parasites using interchangeable optical filters

September 7, 2012 - 07:43 -- Kabogo Ndegwa
Author(s): 
Vorobjev IA, Buchholz K, Prabhat P, Ketman K, Egan E, Marti M, Duraisingh MT, Barteneva NS
Reference: 
Malaria Journal 2012, 11:312 (5 September 2012)

MalariaWorldFilter optimization is particularly important for applications where the FP signal and percentage of positive events are relatively low, such as analysis of parasite-infected samples with in the intention of gene-expression profiling and analysis.

Medical Condition: 

Effects of malaria volunteer training on coverage and timeliness of diagnosis: a cluster randomized controlled trial in Myanmar

September 7, 2012 - 07:30 -- Kabogo Ndegwa
Author(s): 
Ohnmar -, Tun-Min -, San-Shwe -, Than-Win -, Chongsuvivatwong V
Reference: 
Malaria Journal 2012, 11:309 (4 September 2012)

MalariaWorldThe results show that implementing volunteer programmes to improve the coverage of accurate and timely diagnosis with RDT and early treatment may be beneficial but the timeliness of detection and sustainability must be improved.

Medical Condition: 

Malaria resistance genes are associated with the levels of IgG subclasses directed against Plasmodium falciparum blood-stage antigens in Burkina Faso

September 7, 2012 - 07:07 -- Kabogo Ndegwa
Author(s): 
Afridi S, Atkinson A, Garnier S, Fumoux F, Rihet P
Reference: 
Malaria Journal 2012, 11:308 (4 September 2012)

MalariaWorldTaken together, the results support the hypothesis that some polymorphisms affect malaria resistance through their effect on the acquired immune response, and pave the way towards further comprehension of genetic control of an individual's humoral response against malaria.

Country: 
Medical Condition: 

Case Report: Artesunate for Severe Acute Plasmodium falciparum Infection in a Patient with Myasthenia Gravis

September 7, 2012 - 04:34 -- Patrick Sampao
Author(s): 
Nathalie Dournon, Pierre Buffet, Eric Caumes, Bernard Clair and Stéphane Jauréguiberry
Reference: 
Am J Trop Med Hyg 2012 87:435-436

MalariaWorldWe report a case of severe malaria in a patient with underlying myasthenia gravis who was successfully treated with artesunate.

Medical Treatment: 

Analysis of the trap gene provides evidence for the role of elevation and vector abundance in the genetic diversity of Plasmodium relictum in Hawaii

September 5, 2012 - 06:55 -- Kabogo Ndegwa
Author(s): 
Farias ME, Atkinson CT, LaPointe DA, Jarvi SI
Reference: 
Malaria Journal 2012, 11:305 (3 September 2012)

MalariaWorldThe results of this study suggest that pathogen diversity in Hawaii may be driven by a complex interaction of factors including transmission rates, host immune pressures, and parasite-parasite competition.

Province Or State: 

Eurartesim®: a guide to its use in the treatment of uncomplicated Plasmodium falciparum malaria

September 4, 2012 - 14:56 -- Patrick Sampao
Author(s): 
Keating, Gillian M
Reference: 
Drugs & Therapy Perspectives, Volume 28, Number 10, 1 October 2012 , pp. 1-5(5)

MalariaWorldThe Eurartesim® formulation of dihydroartemisinin/piperaquine is the only formulation to meet international good manufacturing practice standards.

Medical Condition: 
Medical Treatment: 

Pages

Subscribe to RSS - Plasmodium falciparum